Sector BriaCell Therapeutics Corp.

Aandelen

BCT

CA1079303071

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 21:58:18 16-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
4,880 CAD -8,96% Intraday-grafiek van BriaCell Therapeutics Corp. -13,01% -50,20%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-8,96%-13,01%-17,43%-7,22%-50,20%-70,50%-99,56%-99,66%-99,95% 30,01 mln.
+1,52%-7,16%-8,44%+24,27%+61,63%+51,66%+67,41%+1,95% - 65 mld.
+0,56%+6,20%+11,08%+7,89%+13,35%+10,24%+78,25%-15,66%+228,09% 51,2 mld.
-0,14%-0,85%-16,24%-3,53%+1,42%-0,41%+61,27%+183,87%+4.859,07% 51,19 mld.
-1,53%+2,70%+0,18%+29,40%+18,41%+30,48%+41,25%+7,42%+249,67% 43,93 mld.
-1,34%+4,12%+5,19%+18,28%+21,48%+16,64%+120,28%+2,29%+1.022,10% 41,96 mld.
-5,97%-6,22%-6,80%-4,40%+123,43%+228,95%+483,48%+535,57% - 38,14 mld.
+2,16%+10,36%+10,48%+12,74%+14,98%+18,92%+59,70%+11,35%+163,60% 33,24 mld.
-0,90%-10,49%-4,27%+30,34%+53,31%+37,09%+1,80%-58,05% - 25,2 mld.
-0,50%-0,12%+9,91%+34,49%+22,55%+25,04%+25,08%-14,64%+116,94% 22,5 mld.
-2,76%-9,54%-8,69%-4,12%-7,87%-16,58%-7,07%-66,41% - 22,03 mld.
-2,96%-4,30%-19,77%-11,12%-44,69%-41,92%+280,81%+265,21%+601,68% 21,02 mld.
-1,61%+1,05%+1,00%+15,01%+10,12%+17,12%+167,71%+232,83%+1.914,56% 17,26 mld.
-5,62%-1,67%-0,42%-1,67%+177,32%+152,60%+374,24%+1.427,38%+748,34% 15,9 mld.
-0,95%+3,96%+6,63%+11,28%+41,98%+58,55%+191,48%+192,02%+433,25% 15,42 mld.
+0,33%+1,11%+0,59%+10,44%+25,83%+22,88%+65,37%-29,43%+85,96% 15,28 mld.
-0,60%-1,74%-4,85%-13,70% - - - - - 14,79 mld.
-1,99%-0,54%+7,94%+33,79%+50,47%+68,13%+62,10%-27,50%+270,19% 14,33 mld.
+3,10%+1,66%-2,08%-7,07%+15,25%-1,40%+496,31% - - 13,77 mld.
-2,83%+3,66%+3,70%+0,11%-6,61%-8,04%-24,91%-38,47%+115,58% 13,13 mld.
Gemiddelde -1,55%-0,76%-1,61%+8,76%+28,53%+31,55%+128,68%+139,45%+764,93% 26,77 mld.
Gewogen gemiddelde per kap. -0,88%-0,25%-1,51%+11,36%+33,23%+39,06%+125,55%+119,60%+1.103,58%
  1. Beurs
  2. Aandelen
  3. Koers BCT
  4. Sector BriaCell Therapeutics Corp.